Table: Oncolys Biopharma -2015 parent results

Oncolys Biopharma

10/02/2016 06:00

Feb 10 (Reuters)-  
          Oncolys Biopharma Inc.  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended        Year to          NEXT      
              Dec 31, 2015    Dec 31, 2014     Dec 31, 2016       YEAR        
                 LATEST         YEAR-AGO         COMPANY          COMPANY     
                 RESULTS         RESULTS         FORECAST       H1 FORECAST   
  Sales          121 mln         28 mln          188 mln          28 mln      
              (+321.2 pct)                     (+55.5 pct)     (+264.1 pct)   
  Operating   loss 951 mln    loss 827 mln      loss 1.27      loss 698 mln   
  Recurring   loss 854 mln    loss 726 mln      loss 1.27      loss 698 mln   
  Net         loss 857 mln    loss 738 mln      loss 1.28      loss 700 mln   
  EPS        loss 93.35 yen  loss 80.55 yen  loss 138.94 yen  loss 76.22 yen  
  Ann Div          NIL             NIL             NIL                        
  -Q2 Div          NIL             NIL             NIL                        
  -Q4 Div          NIL             NIL             NIL                        
   
  NOTE - Oncolys Biopharma Inc..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T  
  ((Tokyo Headline News Desk +813 6441 1812))